NCOA7 has been shown to correlate with the prognosis of various tumors such as neuroblastoma, colon cancer, and breast cancer, among other tumors [16,17,18]; it plays an anticancer role by synergistically enhancing the promoter activity of the all-trans retinoic acid target gene with retinoic acid receptor α (RARα) [16]. This evidence concerns the gene NCOA7 and neuroblastoma.